New Medical Policy: Cluneal Nerve Block for Treatment of Low Back Pain

New Medical Policy: Cluneal Nerve Block for Treatment of Low Back Pain

Effective Aug. 1, 2021, BlueCross BlueShield of South Carolina and BlueChoice® HealthPlan will implement a new medical policy for cluneal nerve blocks.  The policy, CAM 274 – Cluneal Nerve Block for Treatment of Low Back Pain, will be added to the Medical Policies pages of www.BlueChoiceSC.com.

Cluneal nerve blocks are used as a proposed treatment for individuals with cluneal nerve entrapment syndromes causing pain in the low back and buttocks.  Cluneal nerve injections or blocks for the treatment of low back pain is considered investigational and/or unproven and therefore, considered not medically necessary and will continue to be a non-covered service.

For complete information on CAM 274, visit the Medical Policies pages.  You may contact Provider Education using the Provider Education Contact Form if you have any questions about this bulletin.